Hi all

I’m performing the analysis of an iTRAQ data for the first time, I have 
files in .mzML format. The petides were labelled with two iTRAQ reagents 
117 and 119. 

I am able to run the data through the pipeline (X!Tandem, peptide prophet , 
protein prophet ) without quantitation, however I am unable to get it to 
work using Libra.

Firstly, I’ve added these lines to the “modifications” section of the 
tandem parameters file:

<note type="input" label="residue, modification 
mass">144.102063@[,144.102063@K</note>

<note type="input" label="residue, potential modification 
mass">144.102063@Y</note> 

Is this correct?

Secondly, for the Libra condition file I selected the commonly used values 
for an iTRAQ 8-channel and deselected the labels that are not in my dataset?

 this is the Libra condition file that I used:

<?xml version="1.0" encoding="UTF-8"?>

<SUMmOnCondition>

  <fragmentMasses>

    <reagent mz="117.1" />

    <reagent mz="119.1" />

  </fragmentMasses>

  <isotopicContributions>

    <contributingMz value="1">

      <affected mz="2" correction="0" />

    </contributingMz>

    <contributingMz value="2">

      <affected mz="1" correction="0.0014" />

    </contributingMz>

  </isotopicContributions>

  <massTolerance value="0.2" />

  <centroiding type="2" iterations="1" />

  <normalization type="-1" />

  <targetMs level="2" />

  <output type="1" />

  <quantitationFile name="quantitation.tsv" />

  <minimumThreshhold value="20" />

</SUMmOnCondition> 


Also, to what do I set the "Normalization channel"


Any help and advice would be appreciated

 

Thank you 

-- 
You received this message because you are subscribed to the Google Groups 
"spctools-discuss" group.
To view this discussion on the web visit 
https://groups.google.com/d/msg/spctools-discuss/-/2kwPGA4LyVsJ.
To post to this group, send email to [email protected].
To unsubscribe from this group, send email to 
[email protected].
For more options, visit this group at 
http://groups.google.com/group/spctools-discuss?hl=en.

Reply via email to